BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study. J Hepatol 2011;54:760-4. [PMID: 21126790 DOI: 10.1016/j.jhep.2010.07.016] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Schulz P, Shabbir R, Ramakrishnan S, Asrani SK. Acute Alcohol-Associated Hepatitis in the COVID-19 Pandemic — a Structured Review. Curr Transpl Rep 2022. [DOI: 10.1007/s40472-022-00387-w] [Reference Citation Analysis]
2 Ha Y, Jeong I, Kim TH. Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives. Biomedicines 2022;10:2530. [PMID: 36289791 DOI: 10.3390/biomedicines10102530] [Reference Citation Analysis]
3 Geng CX, Gudur AR, Patterson DR, Stotts MJ. Concordance of ICD-10 Codes and the Clinical Diagnosis of Alcoholic Hepatitis. Am J Gastroenterol 2022;117:1706-8. [PMID: 35973184 DOI: 10.14309/ajg.0000000000001886] [Reference Citation Analysis]
4 Wakil A, Mohamed M, Tafesh Z, Niazi M, Olivo R, Xia W, Greenberg P, Pyrsopoulos N. Trends in hospitalization for alcoholic hepatitis from 2011 to 2017: A USA nationwide study. World J Gastroenterol 2022; 28(34): 5036-5046 [DOI: 10.3748/wjg.v28.i34.5036] [Reference Citation Analysis]
5 Israelsen M, Misas MG, Koutsoumourakis A, Hall A, Covelli C, Buzzetti E, Prat LI, Roccarina D, Luong TV, Quaglia A, Pinzani M, Tsochatzis EA. Collagen proportionate area predicts long-term mortality in patients with alcoholic hepatitis. Dig Liver Dis 2022;54:663-8. [PMID: 34548258 DOI: 10.1016/j.dld.2021.08.021] [Reference Citation Analysis]
6 Cabezas J. Management of Alcohol-Related Liver Disease and Its Complications. Clin Drug Investig 2022. [PMID: 35467296 DOI: 10.1007/s40261-022-01143-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Parker R, Cabezas J, Altamirano J, Arab JP, Ventura-Cots M, Sinha A, Dhanda A, Arrese M, McCune CA, Rowe IA, Schnabl B, Mathurin P, Shawcross D, Abraldes JG, Lucey MR, Garcia-Tsao G, Verna E, Brown RS Jr, Bosques-Padilla F, Vargas V, Louvet A, Holt AP, Bataller R. Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2022;20:e289-97. [PMID: 33516950 DOI: 10.1016/j.cgh.2021.01.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Gao B, Wu TC, Lang S, Jiang L, Duan Y, Fouts DE, Zhang X, Tu XM, Schnabl B. Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis. Metabolites 2022;12:41. [PMID: 35050163 DOI: 10.3390/metabo12010041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zanetto A, Shalaby S, Gambato M, Germani G, Senzolo M, Bizzaro D, Russo FP, Burra P. New Indications for Liver Transplantation. J Clin Med 2021;10:3867. [PMID: 34501314 DOI: 10.3390/jcm10173867] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Eriksen LL, Nielsen MA, Laursen TL, Deleuran B, Vilstrup H, Støy S. Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis. PLoS One 2021;16:e0255574. [PMID: 34352016 DOI: 10.1371/journal.pone.0255574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin Liver Dis 2021;25:483-92. [PMID: 34229835 DOI: 10.1016/j.cld.2021.03.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
12 Morgan MY, Sharma M, Atkinson SR. Genetic and Environmental Susceptibility to Alcoholic Hepatitis. Clin Liver Dis 2021;25:517-35. [PMID: 34229837 DOI: 10.1016/j.cld.2021.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Støy S, Laursen TL, Glavind E, Eriksen PL, Terczynska-Dyla E, Magnusson NE, Hamilton-Dutoit S, Mortensen FV, Veidal SS, Rigbolt K, Riggio O, Deleuran B, Vilstrup H, Sandahl TD. Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression. Clin Transl Gastroenterol 2020;11:e00197. [PMID: 32955203 DOI: 10.14309/ctg.0000000000000197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M. Transition to decompensation and acute-on-chronic liver failure: Role of predisposing factors and precipitating events. J Hepatol 2021;75 Suppl 1:S36-48. [PMID: 34039491 DOI: 10.1016/j.jhep.2020.12.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
15 Burra P, Samuel D, Sundaram V, Duvoux C, Petrowsky H, Terrault N, Jalan R. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. J Hepatol 2021;75 Suppl 1:S178-90. [PMID: 34039488 DOI: 10.1016/j.jhep.2021.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
16 Doshi SD, Stotts MJ, Hubbard RA, Goldberg DS. The Changing Burden of Alcoholic Hepatitis: Rising Incidence and Associations with Age, Gender, Race, and Geography. Dig Dis Sci 2021;66:1707-14. [PMID: 32436122 DOI: 10.1007/s10620-020-06346-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Amjad W, Alukal J, Doycheva I, Zhang T, Maheshwari A, Yoo H, Thuluvath PJ. A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis. Dig Dis Sci 2020;65:3726-33. [PMID: 32072435 DOI: 10.1007/s10620-020-06142-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Xiang X, Hwang S, Feng D, Shah VH, Gao B. Interleukin-22 in alcoholic hepatitis and beyond. Hepatol Int 2020;14:667-76. [PMID: 32892258 DOI: 10.1007/s12072-020-10082-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Pokorna V, Bodikova S, Kaluzay J, Liskova Z, Jurkovicova O. Acute limb ischemia due to paradoxical embolism treated with systemic thrombolysis. Vnitr Lek 2020;66:e48-e51. [DOI: 10.36290/vnl.2020.090] [Reference Citation Analysis]
20 Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology 2020;72:441-53. [PMID: 31774566 DOI: 10.1002/hep.31046] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
21 Ehrmann J, Aiglová K, Urban O, Cveková S, Dvoran P. Alcohol-related liver diseases (ALD). Vnitř Lék 2020;66:e3-e15. [DOI: 10.36290/vnl.2020.091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dasarathy S, Mitchell MC, Barton B, McClain CJ, Szabo G, Nagy LE, Radaeva S, McCullough AJ. Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis. Contemp Clin Trials 2020;96:106094. [PMID: 32739495 DOI: 10.1016/j.cct.2020.106094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
23 Degré D, Wandji LCN, Moreno C, Louvet A. Alcoholic hepatitis: Towards an era of personalised management. United European Gastroenterol J 2020;8:995-1002. [PMID: 32718222 DOI: 10.1177/2050640620945886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Nielsen MC, Andersen MN, Grønbæk H, Damgaard Sandahl T, Møller HJ. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease. Scand J Gastroenterol 2020;55:588-96. [PMID: 32393080 DOI: 10.1080/00365521.2020.1759140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
25 Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases.Transl Gastroenterol Hepatol. 2020;5:16. [PMID: 32258520 DOI: 10.21037/tgh.2019.09.08] [Cited by in Crossref: 154] [Cited by in F6Publishing: 159] [Article Influence: 51.3] [Reference Citation Analysis]
26 Neuman MG, Seitz HK, French SW, Malnick S, Tsukamoto H, Cohen LB, Hoffman P, Tabakoff B, Fasullo M, Nagy LE, Tuma PL, Schnabl B, Mueller S, Groebner JL, Barbara FA, Yue J, Nikko A, Alejandro M, Brittany T, Edward V, Harrall K, Saba L, Mihai O. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research. Biomedicines 2020;8:E63. [PMID: 32197424 DOI: 10.3390/biomedicines8030063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
27 Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res 2020;9:F1000 Faculty Rev-97. [PMID: 32089834 DOI: 10.12688/f1000research.20394.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Engelmann C, Tacke F. Dekompensierte Leberzirrhose und akut-auf-chronisches Leberversagen. Gastroenterologe 2020;15:22-33. [DOI: 10.1007/s11377-019-00407-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Hosseini N, Shor J, Szabo G. Alcoholic Hepatitis: A Review. Alcohol Alcohol 2019;54:408-16. [PMID: 31219169 DOI: 10.1093/alcalc/agz036] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 16.0] [Reference Citation Analysis]
30 Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology 2020;71:306-33. [PMID: 31314133 DOI: 10.1002/hep.30866] [Cited by in Crossref: 262] [Cited by in F6Publishing: 209] [Article Influence: 87.3] [Reference Citation Analysis]
31 Chung GE, Heo NJ, Kim D, Kwak MS, Yim JY, Kim JS, Ahmed A. Association between advanced fibrosis in fatty liver disease and overall mortality based on body fat distribution. J Gastroenterol Hepatol 2020;35:90-6. [PMID: 31272131 DOI: 10.1111/jgh.14778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
32 Asrani SK, Trotter J, Lake J, Ahmed A, Bonagura A, Cameron A, DiMartini A, Gonzalez S, Im G, Martin P, Mathurin P, Mellinger J, Rice JP, Shah VH, Terrault N, Wall A, Winder S, Klintmalm G. Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis. Liver Transpl 2020;26:127-40. [PMID: 31743578 DOI: 10.1002/lt.25681] [Cited by in Crossref: 54] [Cited by in F6Publishing: 34] [Article Influence: 18.0] [Reference Citation Analysis]
33 Bennett K, Enki DG, Thursz M, Cramp ME, Dhanda AD. Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis. Aliment Pharmacol Ther 2019;50:249-57. [PMID: 31231848 DOI: 10.1111/apt.15376] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
34 Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P; EASL-AASLD Joint Meeting. Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study. Hepatology 2019;69:2271-83. [PMID: 30645002 DOI: 10.1002/hep.30369] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
35 Lee JY, Cho Y, Hong MH, Kim J, Lee DH, Jung YJ, Kim BG, Lee KL, Kim W. Incidence, inhospital mortality, and readmission among patients with alcoholic hepatitis in Korea: A nationwide study. J Gastroenterol Hepatol 2019;34:747-54. [PMID: 30345539 DOI: 10.1111/jgh.14513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Thursz M, Kamath PS, Mathurin P, Szabo G, Shah VH. Alcohol-related liver disease: Areas of consensus, unmet needs and opportunities for further study. J Hepatol 2019;70:521-30. [PMID: 30658117 DOI: 10.1016/j.jhep.2018.10.041] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
37 Ventura-cots M, Ndugga N, Bataller R. Alcoholic Liver Disease. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch34] [Reference Citation Analysis]
38 Fang H, Zhang AH, Sun H, Yu JB, Wang L, Wang XJ. High-throughput metabolomics screen coupled with multivariate statistical analysis identifies therapeutic targets in alcoholic liver disease rats using liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1109:112-20. [PMID: 30743140 DOI: 10.1016/j.jchromb.2019.01.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
39 Israelsen M, Krag A, Thiele M. Clinical Aspects of Alcoholic Liver Disease. The Human Gut-Liver-Axis in Health and Disease 2019. [DOI: 10.1007/978-3-319-98890-0_1] [Reference Citation Analysis]
40 López-pelayo H, Miquel L, Altamirano J, Bataller R, Caballeria J, Ortega L, Lligoña A, Gual A. Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse. Journal of Psychosomatic Research 2019;116:75-82. [DOI: 10.1016/j.jpsychores.2018.11.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
41 Buyeverov AO, Syutkin VE, Bogomolov PO. Severe alcoholic hepatitis: why do we know a lot, but can do so little? Klin med 2018;96:401-410. [DOI: 10.18821/0023-2149-2018-96-5-401-410] [Reference Citation Analysis]
42 Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. [PMID: 30115921 DOI: 10.1038/s41572-018-0014-7] [Cited by in Crossref: 348] [Cited by in F6Publishing: 382] [Article Influence: 69.6] [Reference Citation Analysis]
43 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol 2018;69:154-81. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 352] [Cited by in F6Publishing: 333] [Article Influence: 70.4] [Reference Citation Analysis]
44 Sandahl TD, Vilstrup H, Jepsen P. The long-term prognosis of alcoholic hepatitis is poor and independent of disease severity for patients surviving an acute episode. J Hepatol 2018;68:1330-1. [PMID: 29524529 DOI: 10.1016/j.jhep.2018.02.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Tiniakos DG, Anstee QM, Burt AD. Fatty Liver Disease. Macsween's Pathology of the Liver 2018. [DOI: 10.1016/b978-0-7020-6697-9.00005-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
46 Stickel F, Datz C, Hampe J, Bataller R. Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver. 2017;11:173-188. [PMID: 28274107 DOI: 10.5009/gnl16477] [Cited by in Crossref: 118] [Cited by in F6Publishing: 129] [Article Influence: 19.7] [Reference Citation Analysis]
47 Burra P, Germani G. Transplantation for acute alcoholic hepatitis. Clin Liver Dis (Hoboken) 2017;9:141-3. [PMID: 30992979 DOI: 10.1002/cld.629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
48 Fung P, Pyrsopoulos N. Emerging concepts in alcoholic hepatitis. World J Hepatol 2017; 9(12): 567-585 [PMID: 28515843 DOI: 10.4254/wjh.v9.i12.567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
49 Parker R, Im G, Jones F, Hernández OP, Nahas J, Kumar A, Wheatley D, Sinha A, Gonzalez-Reimers E, Sanchez-Pérez M, Ghezzi A, David MD, Corbett C, McCune A, Aithal GP, Holt A, Stewart S. Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study. J Gastroenterol 2017;52:1192-200. [PMID: 28389732 DOI: 10.1007/s00535-017-1336-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
50 Lackner C, Spindelboeck W, Haybaeck J, Douschan P, Rainer F, Terracciano L, Haas J, Berghold A, Bataller R, Stauber RE. Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease. J Hepatol 2017;66:610-8. [PMID: 27894795 DOI: 10.1016/j.jhep.2016.11.011] [Cited by in Crossref: 117] [Cited by in F6Publishing: 108] [Article Influence: 19.5] [Reference Citation Analysis]
51 Møller HJ, Kazankov K, Rødgaard-hansen S, Nielsen MC, Sandahl TD, Vilstrup H, Moestrup SK, Grønbæk H. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Barve A, Marsano LS, Parajuli D, Cave M, Mcclain CJ. Alcoholic Liver Disease. In: Saeian K, Shaker R, editors. Liver Disorders. Cham: Springer International Publishing; 2017. pp. 173-97. [DOI: 10.1007/978-3-319-30103-7_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
53 Kim HY, Kim CW, Kim TY, Song DS, Sinn DH, Yoon EL, Jung YK, Suk KT, Lee SS, Lee CH, Kim TH, Kim JH, Yim HJ, Kim SE, Baik SK, Lee BS, Jang JY, Kim YS, Kim SG, Yang JM, Sohn JH, Lee HJ, Park SH, Choi EH, Kim DJ, Korean Acute-on-Chronic Liver Failure Study Group. Assessment of scoring systems for acute-on-chronic liver failure at predicting short-term mortality in patients with alcoholic hepatitis. World J Gastroenterol 2016; 22(41): 9205-9213 [PMID: 27895407 DOI: 10.3748/wjg.v22.i41.9205] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
54 Bouttell J, Lewsey J, Geue C, Antony G, Briggs A, McCartney G, Hutchinson S, Graham L, Heydtmann M. The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011. PLoS One 2016;11:e0162980. [PMID: 27783619 DOI: 10.1371/journal.pone.0162980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
55 Mandrekar P, Bataller R, Tsukamoto H, Gao B. Alcoholic hepatitis: Translational approaches to develop targeted therapies. Hepatology 2016;64:1343-55. [PMID: 26940353 DOI: 10.1002/hep.28530] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
56 Effertz T, Verheyen F, Linder R. The costs of hazardous alcohol consumption in Germany. Eur J Health Econ 2017;18:703-13. [DOI: 10.1007/s10198-016-0822-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
57 Gallegos-Orozco JF, Charlton MR. Alcoholic Liver Disease and Liver Transplantation. Clin Liver Dis 2016;20:521-34. [PMID: 27373614 DOI: 10.1016/j.cld.2016.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
58 Sahlman P, Nissinen M, Pukkala E, Färkkilä M. Incidence, survival and cause-specific mortality in alcoholic liver disease: a population-based cohort study. Scand J Gastroenterol 2016;51:961-6. [PMID: 27181618 DOI: 10.3109/00365521.2016.1157889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
59 Glavind E, Aagaard NK, Grønbæk H, Møller HJ, Orntoft NW, Vilstrup H, Thomsen KL. Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis. PLoS One 2016;11:e0158388. [PMID: 27379798 DOI: 10.1371/journal.pone.0158388] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
60 Laursen TL, Støy S, Deleuran B, Vilstrup H, Grønbaek H, Sandahl TD. The damage-associated molecular pattern HMGB1 is elevated in human alcoholic hepatitis, but does not seem to be a primary driver of inflammation. APMIS 2016;124:741-7. [DOI: 10.1111/apm.12568] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
61 Younossi Z, Henry L. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality. Gastroenterology 2016;150:1778-85. [PMID: 26980624 DOI: 10.1053/j.gastro.2016.03.005] [Cited by in Crossref: 196] [Cited by in F6Publishing: 196] [Article Influence: 28.0] [Reference Citation Analysis]
62 Thursz M, Morgan TR. Treatment of Severe Alcoholic Hepatitis. Gastroenterology 2016;150:1823-34. [PMID: 26948886 DOI: 10.1053/j.gastro.2016.02.074] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
63 Farooq MO, Bataller R. Pathogenesis and Management of Alcoholic Liver Disease. Dig Dis 2016;34:347-55. [PMID: 27170388 DOI: 10.1159/000444545] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
64 Nguyen TA, DeShazo JP, Thacker LR, Puri P, Sanyal AJ. The Worsening Profile of Alcoholic Hepatitis in the United States. Alcohol Clin Exp Res 2016;40:1295-303. [PMID: 27147285 DOI: 10.1111/acer.13069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
65 Arsene D, Farooq O, Bataller R. New therapeutic targets in alcoholic hepatitis. Hepatol Int 2016;10:538-52. [PMID: 27072540 DOI: 10.1007/s12072-015-9701-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
66 Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G; NIAAA Alcoholic Hepatitis Consortia. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016;150:785-90. [PMID: 26921783 DOI: 10.1053/j.gastro.2016.02.042] [Cited by in Crossref: 263] [Cited by in F6Publishing: 263] [Article Influence: 37.6] [Reference Citation Analysis]
67 Møller HJ, Kazankov K, Rødgaard-hansen S, Nielsen MC, Sandahl TD, Vilstrup H, Moestrup SK, Grønbæk H. Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016. [DOI: 10.1007/978-94-007-7742-2_40-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Marsano LS, Vatsalya V, Hassan A, Mcclain CJ. Clinical Features, Disease Modifiers, and Natural History of Alcoholic Liver Disease. Alcoholic and Non-Alcoholic Fatty Liver Disease 2016. [DOI: 10.1007/978-3-319-20538-0_8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
69 Horie Y, Ebinuma H, Kikuchi H, Shiba S, Nakamoto N, Kanai T. Current status of alcoholic hepatitis in Japan (2012). Acta hepatologica Japonica 2016;57:171-177. [DOI: 10.2957/kanzo.57.171] [Reference Citation Analysis]
70 Altamirano J, Orman ES, Bataller R. Alcoholic Liver Disease. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch103] [Reference Citation Analysis]
71 Dhanda AD, Collins PL. Immune dysfunction in acute alcoholic hepatitis. World J Gastroenterol 2015; 21(42): 11904-11913 [PMID: 26576079 DOI: 10.3748/wjg.v21.i42.11904] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
72 Pang JX, Ross E, Borman MA, Zimmer S, Kaplan GG, Heitman SJ, Swain MG, Burak KW, Quan H, Myers RP. Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data. BMC Gastroenterol 2015;15:116. [PMID: 26362871 DOI: 10.1186/s12876-015-0348-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
73 Rahimi E, Pan JJ. Prognostic models for alcoholic hepatitis. Biomark Res 2015;3:20. [PMID: 26203357 DOI: 10.1186/s40364-015-0046-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
74 Jinjuvadia R, Liangpunsakul S; Translational Research and Evolving Alcoholic Hepatitis Treatment Consortium. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States. J Clin Gastroenterol 2015;49:506-11. [PMID: 25198164 DOI: 10.1097/MCG.0000000000000161] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 9.6] [Reference Citation Analysis]
75 Yang ZH, Yang SX, Qin CZ, Chen YX. Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis. Hepat Mon 2015;15:e25328. [PMID: 26045704 DOI: 10.5812/hepatmon.15(5)2015.25328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
76 Mathurin P, Bataller R. Trends in the management and burden of alcoholic liver disease. J Hepatol 2015;62:S38-46. [PMID: 25920088 DOI: 10.1016/j.jhep.2015.03.006] [Cited by in Crossref: 187] [Cited by in F6Publishing: 193] [Article Influence: 23.4] [Reference Citation Analysis]
77 Støy S, Dige A, Sandahl TD, Laursen TL, Buus C, Hokland M, Vilstrup H. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2015;308:G269-76. [PMID: 25501547 DOI: 10.1152/ajpgi.00200.2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
78 Deleuran T, Vilstrup H, Becker U, Jepsen P. Epidemiology of Alcoholic Liver Disease in Denmark 2006–2011: A Population-Based Study. Alcohol and Alcoholism 2015;50:352-7. [DOI: 10.1093/alcalc/agv003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
79 Sandahl TD, Grønbaek H, Møller HJ, Støy S, Thomsen KL, Dige AK, Agnholt J, Hamilton-Dutoit S, Thiel S, Vilstrup H. Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study. Am J Gastroenterol 2014;109:1749-56. [PMID: 25155228 DOI: 10.1038/ajg.2014.262] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
80 Wernlund PG, Støy S, Lemming L, Vilstrup H, Sandahl TD. Blood culture-positive infections in patients with alcoholic hepatitis. Scandinavian Journal of Infectious Diseases 2014;46:902-5. [DOI: 10.3109/00365548.2014.951682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
81 Sundaram V, May FP, Manne V, Saab S. Effects of Clostridium difficile infection in patients with alcoholic hepatitis. Clin Gastroenterol Hepatol 2014;12:1745-52.e2. [PMID: 24681081 DOI: 10.1016/j.cgh.2014.02.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
82 Orntoft NW, Sandahl TD, Jepsen P, Vilstrup H. Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark. Clin Gastroenterol Hepatol 2014;12:1739-44.e1. [PMID: 24780287 DOI: 10.1016/j.cgh.2014.04.020] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
83 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492-510. [PMID: 25217800 DOI: 10.1016/j.yexmp.2014.09.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
84 Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014; 20(33): 11684-11699 [PMID: 25206273 DOI: 10.3748/wjg.v20.i33.11684] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 92] [Article Influence: 9.3] [Reference Citation Analysis]
85 Streba LA, Vere CC, Streba CT, Ciurea ME. Focus on alcoholic liver disease: from nosography to treatment. World J Gastroenterol 2014;20:8040-7. [PMID: 25009375 DOI: 10.3748/wjg.v20.i25.8040] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
86 Casanova J, Bataller R. Alcoholic hepatitis: Prognosis and treatment. Gastroenterol Hepatol. 2014;37:262-268. [PMID: 24656653 DOI: 10.1016/j.gastrohep.2014.02.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
87 Gelu-simeon M, Duclos-vallee J, Samuel D. Liver transplantation for alcoholic hepatitis. Current situation and future. Hepatol Int 2014;8:481-5. [DOI: 10.1007/s12072-013-9508-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of alcoholic liver disease. Clin Mol Hepatol. 2013;19:216-254. [PMID: 24133661 DOI: 10.3350/cmh.2013.19.3.216] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
89 Thuluvath PJ, Ahn E, Nguyen GC. Hepatitis C as a prognostic indicator among noncirrhotic patients hospitalized with alcoholic hepatitis. Can J Gastroenterol 2013;27:639-42. [PMID: 24040630 DOI: 10.1155/2013/930827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
90 Wieser V, Tilg H. [Management of severe alcoholic hepatitis]. Wien Med Wochenschr 2014;164:3-8. [PMID: 23842647 DOI: 10.1007/s10354-013-0221-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
91 Matos L, Batista P, Monteiro N, Henriques P, Carvalho A. Hepatite alcoólica aguda - Artigo de revisão. GE Jornal Português de Gastrenterologia 2013;20:153-161. [DOI: 10.1016/j.jpg.2013.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
92 Parker R, Armstrong MJ, Corbett C, Rowe IA, Houlihan DD. Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis. Aliment Pharmacol Ther 2013;37:845-54. [PMID: 23489011 DOI: 10.1111/apt.12279] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
93 Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F. The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 2013;58:593-608. [PMID: 23419824 DOI: 10.1016/j.jhep.2012.12.005] [Cited by in Crossref: 862] [Cited by in F6Publishing: 895] [Article Influence: 86.2] [Reference Citation Analysis]
94 Støy S, Sandahl TD, Dige AK, Agnholt J, Rasmussen TK, Grønbæk H, Deleuran B, Vilstrup H. Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PLoS One 2013;8:e55101. [PMID: 23372820 DOI: 10.1371/journal.pone.0055101] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
95 Smart L, Gobejishvili L, Crittenden N, Barve S, McClain CJ. Alcoholic Hepatitis: Steroids vs. Pentoxifylline. Curr Hepat Rep 2013;12:59-65. [PMID: 23750115 DOI: 10.1007/s11901-012-0158-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
96 Palaniyappan N, Subramanian V, Ramappa V, Ryder SD, Kaye P, Aithal GP. The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: whose score is it anyway? Int J Hepatol. 2012;2012:624675. [PMID: 22988517 DOI: 10.1155/2012/624675] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
97 European Association for the Study of Liver. EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399-420. [PMID: 22633836 DOI: 10.1016/j.jhep.2012.04.004] [Cited by in Crossref: 450] [Cited by in F6Publishing: 470] [Article Influence: 40.9] [Reference Citation Analysis]
98 Deleuran T, Grønbaek H, Vilstrup H, Jepsen P. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Aliment Pharmacol Ther 2012;35:1336-42. [PMID: 22490057 DOI: 10.1111/j.1365-2036.2012.05091.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
99 Mathurin P, Lucey MR. Management of alcoholic hepatitis. J Hepatol 2012;56 Suppl 1:S39-45. [PMID: 22300464 DOI: 10.1016/S0168-8278(12)60005-1] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 8.4] [Reference Citation Analysis]
100 Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011;46:1127-32. [PMID: 21591871 DOI: 10.3109/00365521.2011.587200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]